In non-alcoholic fatty liver disease, upregulation of PPARγ expression significantly inhibited saturated fatty acids-induced NF-κB activation and resulted in macrophage polarization into an M2 phenotype [30]. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.